Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren’s syndrome through the secretion of indoleamine 2,3-dioxygenase-Reference-Cited by-同舟云学术

Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren’s syndrome through the secretion of indoleamine 2,3-dioxygenase

Published:2014-08-27 Issue:2 Volume:54 Page:332-342
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Liu Rui,Su Dinglei,Zhou Min,Feng Xuebing,Li Xia,Sun Lingyun

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/54/2/332/17388650/keu316.pdf

Reference48 articles.

1. Sjogren’s syndrome;Fox;Lancet,2005

2. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren’s syndrome;Amft;Arthritis Rheum,2001

3. B cells in Sjogren’s syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue;Hansen;Arthritis Res Ther,2007

4. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression;Rasheed;Eur J Immunol,2006

5. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation;Haynes;J Immunol,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and therapeutic potentials of extracellular vesicles for primary Sjögren's Syndrome: A review;Dentistry Review;2024-09

2. T follicular helper cells and T follicular regulatory cells in autoimmune diseases;Frontiers in Immunology;2023-04-28

3. Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4+ T cells in patients with primary Sjögren's syndrome;Inflammopharmacology;2023-04-03

4. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors’ Repertoire in the Recovery of Systemic Lupus Erythematosus;Stem Cell Reviews and Reports;2022-10-22

5. Mesenchymal stem cell transplantation alleviates Sjögren's syndrome symptoms by modulating Tim-3 expression;International Immunopharmacology;2022-10